Bausch Health Companies Inc Stock price Toronto S.E.
Equities
CA91911K1021
Pharmaceuticals
Sales 2024 * | 9.39B 12.77B | Sales 2025 * | 9.21B 12.52B | Capitalization | 3.83B 5.21B |
---|---|---|---|---|---|
Net income 2024 * | 220M 299M | Net income 2025 * | 11M 14.96M | EV / Sales 2024 * | 2.53 x |
Net Debt 2024 * | 19.91B 27.07B | Net Debt 2025 * | 18.33B 24.93B | EV / Sales 2025 * | 2.41 x |
P/E ratio 2024 * |
16.7
x | P/E ratio 2025 * |
525
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.37% |
Latest transcript on Bausch Health Companies Inc
Managers | Title | Age | Since |
---|---|---|---|
Thomas Appio
CEO | Chief Executive Officer | 61 | - |
John Barresi
DFI | Director of Finance/CFO | 51 | 22-05-23 |
Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Power
BRD | Director/Board Member | 67 | 08-07-31 |
John Paulson
CHM | Chairman | 68 | 17-05-31 |
Steven Miller
BRD | Director/Board Member | 35 | 21-03-16 |
1st Jan change | Capi. | |
---|---|---|
+33.50% | 701B | |
+26.24% | 571B | |
+0.78% | 381B | |
+20.85% | 334B | |
+16.38% | 319B | |
+2.63% | 210B | |
+1.00% | 210B | |
-6.71% | 201B | |
-3.51% | 157B |